Nanoviricides Inc (NNVC)
2.07
-0.16
(-7.17%)
USD |
NYAM |
May 17, 16:00
2.08
+0.01
(+0.48%)
After-Hours: 20:00
Nanoviricides Price: 2.07 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 2.22 | 2.25 | 2.00 | 2.07 | 222222.0 |
May 16, 2024 | 1.89 | 2.29 | 1.86 | 2.23 | 595427.0 |
May 15, 2024 | 2.25 | 2.25 | 1.78 | 1.80 | 343117.0 |
May 14, 2024 | 1.98 | 2.26 | 1.87 | 2.26 | 671455.0 |
May 13, 2024 | 1.95 | 2.050 | 1.80 | 1.82 | 143371.0 |
May 10, 2024 | 1.57 | 1.90 | 1.56 | 1.89 | 192660.0 |
May 09, 2024 | 2.12 | 2.13 | 1.80 | 1.83 | 532944.0 |
May 08, 2024 | 1.70 | 2.07 | 1.69 | 2.03 | 710383.0 |
May 07, 2024 | 1.60 | 1.80 | 1.45 | 1.68 | 520443.0 |
May 06, 2024 | 1.21 | 1.59 | 1.20 | 1.40 | 1.068M |
May 03, 2024 | 1.12 | 1.170 | 1.10 | 1.13 | 26413.00 |
May 02, 2024 | 1.155 | 1.20 | 1.12 | 1.20 | 11733.00 |
May 01, 2024 | 1.23 | 1.23 | 1.13 | 1.13 | 7868.00 |
Apr 30, 2024 | 1.157 | 1.27 | 1.14 | 1.20 | 62809.00 |
Apr 29, 2024 | 1.10 | 1.13 | 1.10 | 1.13 | 25551.00 |
Apr 26, 2024 | 1.10 | 1.130 | 1.10 | 1.10 | 5699.00 |
Apr 25, 2024 | 1.11 | 1.152 | 1.030 | 1.11 | 26304.00 |
Apr 24, 2024 | 1.14 | 1.15 | 1.13 | 1.15 | 13981.00 |
Apr 23, 2024 | 1.20 | 1.20 | 1.11 | 1.14 | 11602.00 |
Apr 22, 2024 | 1.10 | 1.170 | 1.10 | 1.12 | 14831.00 |
Apr 19, 2024 | 1.19 | 1.19 | 1.09 | 1.10 | 22510.00 |
Apr 18, 2024 | 1.15 | 1.208 | 1.15 | 1.175 | 13093.00 |
Apr 17, 2024 | 1.18 | 1.23 | 1.15 | 1.16 | 7733.00 |
Apr 16, 2024 | 1.17 | 1.223 | 1.17 | 1.18 | 8623.00 |
Apr 15, 2024 | 1.250 | 1.29 | 1.13 | 1.15 | 75187.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.02
Minimum
Nov 27 2023
16.76
Maximum
Jan 31 2020
3.219
Average
2.60
Median
Sep 27 2019
Price Benchmarks
EyePoint Pharmaceuticals Inc | 11.84 |
Enanta Pharmaceuticals Inc | 12.12 |
GlycoMimetics Inc | 0.2964 |
FibroGen Inc | 1.205 |
Corvus Pharmaceuticals Inc | 2.29 |
Price Related Metrics
Price to Book Value | 2.289 |
Earnings Yield | -39.61% |
Market Cap | 24.38M |